Investing
Editor's Top Picks
Your one-stop resource for personal news and tips.
More form Investing
Ford’s U.S. sales rise 11% in latest quarter
Shares of Ford Motor Co. fell nearly 2% Thursday, pulling back from a 10-month closing…
As Rates Spike, Here Are Three Investment Strategies To Consider
The U.S. Federal Reserve has increased short-term interest rates from practically zero in early 2022…
Twitter CEO responds to Meta Threads: ‘We’re often imitated’
That was Twitter CEO Linda Yaccarino in a tweet on Thursday morning, which appeared to…
Are Investors Cashing In From Two-Year Old Infrastructure Law Yet?
Two years ago, on Nov. 15, 2021, the Bipartisan Infrastructure Bill was signed into law,…
Mullen Automotive’s stock more than doubles in 2 days. Here’s why.
Shares of Mullen Automotive Inc. rocketed on massive volume for a second-straight day, after the…
High Dividend SOE Trade Comes Off In A Hurry
Key News Asian equities had a rough night, except India, on the specter of higher…
Oil prices end at a 2-week high on reports Saudi Arabia said OPEC+ will do ‘whatever necessary’ to support oil
Oil futures settle at their highest in two weeks on Wednesday, finding support after Saudi…
Barbie Owner Mattel Plans 45 More Toy Movies As IP And Nostalgia Trend Continues
Key Takeaways The Barbie movie is shaping up to be one of the biggest box…
Gold prices end lower as investors weigh prospects for Fed interest rates
Gold prices finished lower Wednesday, then extended their decline in electronic trading as minutes of…
Acasti Pharma, FDA Agree on GTX-104 Phase 3 Trial Protocol
By Robb M. Stewart Acasti Pharma said Wednesday it has aligned with the U.S. Food…
Abbott Labs Gets FDA OK for Aveir Dual-Chamber Leadless Pacemaker System >ABT
By Colin Kellaher Abbott Laboratories on Wednesday said the U.S. Food and Drug Administration gave…
Currys Seen With Pretax Loss for FY 2023 Amid Nordic Headwinds — Earnings Preview
By Christian Moess Laursen Currys is scheduled to report results for fiscal 2023 on Thursday.…
Release Of Fed Minutes Supports July Hike
Minutes from the Federal Reserve’s June meeting at which rates were held steady pointed to…
RVL Pharma Shares Rise 9% After Board Considers Strategic Alternatives
By Chris Wack RVL Pharmaceuticals shares were up 9% to 60 cents after the company…
C4 Therapeutics Shares Up 18% After Lung Cancer Drug Application Receives FDA Clearance
By Dean Seal Shares of C4 Therapeutics are trading higher Wednesday after the company said…